FOCAL POINTS (Courageous Discourse)

FOCAL POINTS (Courageous Discourse)

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
Prevalence of Statin Intolerance: a Meta-analysis

Prevalence of Statin Intolerance: a Meta-analysis

Frequently Recommended Drugs Hit Brick Wall of Perceived Intolerance

Peter A. McCullough, MD, MPH's avatar
Peter A. McCullough, MD, MPH
Jul 10, 2024
∙ Paid
96

Share this post

FOCAL POINTS (Courageous Discourse)
FOCAL POINTS (Courageous Discourse)
Prevalence of Statin Intolerance: a Meta-analysis
62
5
Share
Upgrade to paid to play voiceover

By Peter A. McCullough, MD, MPH

Hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors, also known as "statins," are used adjunctively to diet and exercise to treat hypercholesterolemia by lowering total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG) concentrations resulting in ~20% and ~30% reductions in atherosclerotic cardiovascular disease outcomes at 2 years in those without and with baseline disease. This month, simvastatin will be available over-the-counter in the United Kingdom as other countries have allowed OTC sales for years.

I often find resistance among prospective patients who have never taken a tablet because they anticipate they will have problems including muscle aches. But how common is this problem?

Keep reading with a 7-day free trial

Subscribe to FOCAL POINTS (Courageous Discourse) to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Peter McCullough MD MPH
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share